MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease – Insights from an Indian Parkinson’s Registry

    N. Sawal, K. Shukla (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. Study evaluated how many patient were spacing  levodopa correctly, its effect on…
  • 2019 International Congress

    Posterior cortical atrophy (PCA) attributable to corticobasal degeneration

    H. Sienkiewicz-Jarosz, E. Bucior (Warsaw, Poland)

    Objective: Introduction: PCA is a clinico-radiological syndrome characterized by progressive decline in visual processing and other posterior cognitive functions, relatively intact memory and language in…
  • 2019 International Congress

    A Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson’s Disease Complicated By “OFF” Episodes

    F. Stocchi, K. Wilks, E. Peckham, M. de Pandis, K. Sciarappa, F. Agbo, R. Kleiman, D. Blum, B. Navia (Rome, Italy)

    Objective: To assess the effect of apomorphine sublingual film (APL130277; APL) on the QT interval in patients with Parkinson’s disease (PD) and “OFF” episodes participating…
  • 2019 International Congress

    Identification of potential new genes involved in autosomal recessive forms of Parkinson’s disease

    C. Tesson, A. Honoré, V. Drouet, H. Bertrand, S. Lesage, A. Brice (Paris, France)

    Objective: The aim of the work is to identify new genes involved in autosomal recessive (AR) early-onset (EO, >40 years) Parkinson disease (PD), using consanguineous…
  • 2019 International Congress

    Lip movement contribution in speech production of persons with Parkinson’s Disease

    P. Upadhyay, S. Gudwani, K. Sharma, R. Sagar, R. Dhamija, S. Kumaran (New Delhi, India)

    Objective: Lip movements contribute to communication by producing labial sounds, conveying facial expression and aiding visually in speech perception. This study planned to understand lip-movements…
  • 2019 International Congress

    The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Healthcare Resource Utilization (HCRU)

    T. Xie, X. Ye, J. de Courcy, J. Mellor, J. Zamudio, L. Chiodo, Y. Bao (Mettawa, IL, USA)

    Objective: To measure the impact of PSP disease severity on HCRU in a real-world setting. Background: PSP is a neurodegenerative disease. As it progresses, patients’…
  • 2019 International Congress

    The Chinese Parkinson’s disease Registry scheme

    XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Q. Xu, Y. Tian, LJ. Fang, ZQ. Wang, QY. Sun, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This large prospective longitudinal cohort aims to identify nature history of a highly-presentative Chinese PD population and to discern clinical and genetic markers which…
  • 2019 International Congress

    Motor-based assessment of prodromal Parkinson’s disease combining wearable sensors and machine learning

    E. Rovini, A. Moschetti, L. Fiorini, D. Esposito, C. Maremmani, F. Cavallo (Pontedera, Italy)

    Objective: To provide the neurologist with a decision support system based on inertial sensors and learning algorithms for an objective early diagnosis of Parkinson’s disease…
  • 2019 International Congress

    Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

    A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

    Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…
  • 2019 International Congress

    Impaired intracortical inhibition predicts response to medication in Parkinson’s disease patients

    SR. Filipović, A. Kačar, S. Milanović, M. Ljubisavljević, VS. Kostić (Beograd, Serbia)

    Objective: To check whether measures of motor cortex excitability and plasticity are associated with clinical response to dopaminergic treatment in Parkinson’s disease (PD) patients. Background:…
  • 1
  • 2
  • 3
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley